There is no treatment of proven efficacy for CADASIL. Antiplatelet treatment is frequently used, but not proven effective in CADASIL.

Migraine should be treated symptomatically and prophylactically, depending on the frequency of manifestations. There is no evidence that triptans and ergot derivatives should be avoided, although some argue that vasoconstrictive medication should be used with prudence.

Co-occurrence of hypertension, diabetes, or hypercholesterolemia should be treated.

Supportive care in the form of practical help, emotional support, and counseling are appropriate for affected individuals and their families.

Further discussion of medical management options for individuals with CADASIL was published by del Río-Espínola et al [2009].
